ENEA

ENEA society

[ENEA @ENEAssoc]

📣 The abstract submission deadline for the 22nd Congress of ENEA has been extended to May 20, 2026 (23:59)!

Don’t miss your chance to present your work in Paris, Sept 9–12, 2026 🇫🇷

[EYRC @ENEA_Young]

🚨 Deadline extended: EYRC @ ENEA 2026! 🇫🇷

Great news — the abstract submission deadline for the 22nd Congress of the European Neuroendocrine Association in Paris has been extended to May 20th, 2026 (23:59)!

Don’t miss your chance to present your work in Paris, Sept 9–12, 2026.

[ENEA @ENEAssoc]

Join us in Paris 🇫🇷 for the 22nd ENEA Congress!

Submit your abstract here: https://t.co/HzTY5bMv5t

[EYRC @ENEA_Young]

🚨 Reminder: EYRC @ ENEA 2026 – Deadline approaching! 🇫🇷

Don’t miss your chance to present at the 22nd Congress of the European Neuroendocrine Association in Paris (Sept 9–12, 2026)!

🔗 Submit here: https://t.co/GYtXugJBp1

[Niki Karavitaki @Karavitaki_Niki]

Another ENEA Workshop is over! “Changing the paradigms over 20 years - a translational approach in pituitary tumours”Marseille, France. Wonderful meeting, many congratulations to the organisers! Save dates for next ENEA conferences Sept 2026, Paris & Sept 2028, Crete @ENEAssoc

[EYRC @ENEA_Young]

📢 Call for Abstracts – #ENEAWorkshop2025 🇫🇷
📅 3–5 Dec | Marseille
Theme: Changing the Paradigms – Translational Approach in Pituitary Tumors
📌 Deadline: 15 Sept 2025

✍️ Max 300 words | <41y = YIA eligible
📩 [email protected]
🔗 https://t.co/A6h98kA0T1

[ENEA @ENEAssoc]

Follow us also on Instagram 👉

https://t.co/bzOwcfsF0k

[ENEA @ENEAssoc]

📢Cushing's Awareness Day

Early diagnosis & treatment can reverse many features of Cushing's syndrome, but some comorbidities persist & quality of life remains compromised.

Hence, it is important to increase early detection of Cushing's syndrome, including Cushing's disease.

[Niki Karavitaki @Karavitaki_Niki]

Thromboprophylaxis in patients with endogenous Cushing's remains a hot topic. Our just released Position Statement is available at DOI: 10.1093/ejendo/lvaf017 @UoB_MSS @BHPComms @ESEndocrinology @PituitarySociety @ENEAssoc @Pituitary_org

[European Society of Endocrinology (ESE) @ESEndocrinology]

Registration is now open!

ESE Spotlight on Science in collaboration with @ENEAssoc (ENEA) will take place on 24 April #WorldHormoneDay at 18:00-19:30 CEST.

Register now!
👉https://t.co/nzbk0jxkze
#BecauseHormonesMatter #Neuroendocrinology

[European Society of Endocrinology (ESE) @ESEndocrinology]

A special Spotlight on Science on #WorldHormoneDay!

Join chairs @ManuelDGahete @LinaPaschou & speaker Manuel Puig Domingo to discuss 'Hormones as potential tools in precision medicine', in collaboration with @ENEAssoc.

📅24 April, 18:00 CEST

Register!
https://t.co/TNc2hJqDMk

[EYRC @ENEA_Young]

🔆 Neuroendocrinology Watch 🔆
“Phenotype of Pediatric Cushing Syndrome without Obesity” Padilla C et al., EJE, 2024

• Non-obese patients: older, mostly female, advanced puberty.
• Different BP profiles by obesity status.
• Weight gain not the only clue—screen for hypercort.

[EYRC @ENEA_Young]

🔆 Neuroendocrinology Watch 🔆 highlithing Lin B et al., Adv Sci 2024, reveal microbiome-metabolome links in craniopharyngioma.

- ↑ Clostridium & disrupted purine metabolism
- Hypoxanthine ↔ hypothalamic comorbidities
- Redox imbalance fuels CP progression

[EYRC @ENEA_Young]

🚨 The 10th EYRC Training Program interview is live! 🎥

@GP_R101 sat down wit @mariachzatelli , esteemed endocrinologist and ESE secretary, during #ECE2024 in Stockholm.

Prof. Zatelli recounted EYRC's founding at ENEA 2012 in Vienna (and yes, there's a parmigiano 🧀 story)!

[EYRC @ENEA_Young]

🔆Neuroendocrinology Watch🔆 New insights on papillary CP treated with BRAF/MEK inh. by Alcubierre et al:
🔹 94% response, with improved headaches, vision & neuro symptoms.
🔹 Tumor volume reduction: 89% (neoadj.), 73% (adj.), 92% (pallia.).
🔹 63% tolerated treatment well

[EndoMedia @EndoMedia]

Breaking news: @TheEndoSociety releases new Scientific Statement on how #opioids affect hormone health. https://t.co/OeKAbMMBCZ

Read the full statement in #EndocrineReviews. https://t.co/T1h9ClAbSv @EndoSocJournals #opioid @Karavitaki_Niki

[EYRC @ENEA_Young]

🚨 Neuroendocrinology Watch highlighting the paper by Lin et al in Genome Medicine.

🧠 Key insights:
1️⃣ Single-cell transcriptomics of 23 PitNETs.
2️⃣ Discovery of 5 potential macrophage subtypes.
3️⃣ CX3CR1+ macrophages may induce tumor apoptosis via the INHBA-ACVR1B axis.

[EYRC @ENEA_Young]

🚨 Neuroendocrinology Watch spotlighting Piña et al.

1⃣ Gene expression annotations align with pathologists' findings.
2⃣Notable intratumor heterogeneity observed in cell clusters.
3⃣Spatial transcriptomics shows promise for small pituitary tumors without multiple stains.

[EYRC @ENEA_Young]

🚨 Neuroendocrinology Watch spotlighting Mamelak et al. in JCEM.

1️⃣Surgery for severe cases, but med & surgic. outcomes similar in 100 apoplexy cases
2️⃣Timing of surgery didn’t affect outcomes—expert neurosurgeon transfer is key
3️⃣Med mgmt reduced tumor volume at 3 months

[EYRC @ENEA_Young]

🚨 Exciting news from the EYRC! 🚨

Introducing #NeuroendocrinologyWatch 🧠🔬— every two weeks, we’ll spotlight cutting-edge research in neuroendocrinology.

Stay tuned for the latest breakthroughs, insights, and must-read papers! 📄✨

First feature coming soon! 👀 @ENEAssoc